DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Hegewisch-Becker S. et al.
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.

Lancet Oncol 2015;
16: 1355-1369

Download Bibliographical Data

Search in:
Access: